GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 77 filers reported holding GENERATION BIO CO in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $37,921 | +103.3% | 13,447 | +193.3% | 0.00% | – |
| Q1 2024 | $18,657 | +29.7% | 4,584 | -47.4% | 0.00% | – |
| Q4 2023 | $14,385 | -56.0% | 8,718 | +1.0% | 0.00% | -100.0% |
| Q3 2023 | $32,715 | +46.2% | 8,632 | +112.1% | 0.00% | 0.0% |
| Q2 2023 | $22,380 | +131547.1% | 4,069 | +4.1% | 0.00% | 0.0% |
| Q1 2023 | $17 | +30.8% | 3,910 | +18.6% | 0.00% | 0.0% |
| Q4 2022 | $13 | -100.0% | 3,298 | -46.6% | 0.00% | 0.0% |
| Q3 2022 | $33,000 | -52.9% | 6,178 | -42.4% | 0.00% | -50.0% |
| Q2 2022 | $70,000 | +775.0% | 10,735 | +853.4% | 0.00% | – |
| Q1 2022 | $8,000 | -78.9% | 1,126 | -79.0% | 0.00% | -100.0% |
| Q4 2021 | $38,000 | -66.4% | 5,358 | +18.9% | 0.00% | -66.7% |
| Q3 2021 | $113,000 | +50.7% | 4,507 | +60.7% | 0.00% | +50.0% |
| Q2 2021 | $75,000 | +47.1% | 2,804 | +57.4% | 0.00% | +100.0% |
| Q1 2021 | $51,000 | +15.9% | 1,781 | +13.6% | 0.00% | 0.0% |
| Q4 2020 | $44,000 | -38.9% | 1,568 | -33.1% | 0.00% | 0.0% |
| Q3 2020 | $72,000 | – | 2,345 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,279,484 | $35,601,781 | 4.82% |
| GREAT POINT PARTNERS LLC | 1,022,537 | $4,396,909 | 0.86% |
| Artal Group S.A. | 2,814,191 | $12,101 | 0.72% |
| PFM Health Sciences, LP | 2,648,297 | $11,387,677 | 0.50% |
| SVB FINANCIAL GROUP | 40,401 | $173,724 | 0.33% |
| SECTORAL ASSET MANAGEMENT INC | 385,070 | $1,655,801 | 0.32% |
| Yiheng Capital Management, L.P. | 1,601,766 | $6,887,594 | 0.27% |
| EcoR1 Capital, LLC | 1,956,579 | $8,413,290 | 0.27% |
| HARVARD MANAGEMENT CO INC | 510,354 | $2,194,522 | 0.23% |
| Bellevue Group AG | 3,620,280 | $15,567,204 | 0.23% |